Occupational Chronic Hand Dermatitis in Hospital Environment Successfully Treated with Dupilumab: A Case Report.

IF 16.4 1区化学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Accounts of Chemical Research Pub Date : 2022-08-12 DOI:10.18502/ijaai.v21i4.10296

Hui Gan, Ya-Dong Gao

引用次数: 2

Abstract

Duplilumab is approved to treat mild to moderate atopic dermatitis. It is unclear, however, whether Dupilumab is effective for occupational hand eczema. In this article, we describe a 29-year-old nurse who developed severe hand eczema after working in a hospital for 6 years and received inadequate relief from routine treatment. Duplilumab was administered to the patient with great results.

查看原文本刊更多论文

杜匹单抗治疗医院环境下职业性慢性手部皮炎1例

杜普单抗被批准用于治疗轻度至中度特应性皮炎。然而，尚不清楚Dupilumab对职业性手湿疹是否有效。在这篇文章中，我们描述了一位29岁的护士，她在医院工作6年后患上了严重的手部湿疹，常规治疗没有得到充分的缓解。杜普单抗被应用于患者，取得了很好的效果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Accounts of Chemical Research 化学-化学综合

CiteScore

31.40

自引率

1.10%

发文量

312

审稿时长

2 months

期刊介绍： Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.